Citations
Mayo Clinic
896 citation(s) found for "Myers, R".
Integrative Genomics Identifies a High-Risk Metabolic and TME Depleted Signature That Predicts Early Clinical Failure in DLBCL
Wenzl, Kerstin , Stokes, Matthew E. , Khan, Sana, Hopper, Melissa A. , Dropik, Abigail R. , Sarangi, Vivekananda , Mwangi, Raphael , Huang, C. Chris , Asmann, Yan W. , Ansell, Stephen M. , King, Rebecca L. , Nowakowski, Grzegorz S. , Gandhi, Anita K. , Novak, Anne J. , Novak, Joseph P. , Krull, Jordan E. , Ortiz, Maria, Stong, Nicholas , Maurer, Matthew J. , Rimsza, Lisa M. , Link, Brian K. , Slager, Susan L. , Mondello, Patrizia , Morin, Ryan D , Habermann, Thomas M. , Feldman, Andrew L. , Cerhan, James R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1742-1744
A Pilot Study of Azacitidine As Epigenetic Priming for Chemotherapy in Infants Less Than 1 Year of Age with KMT2A-Rearranged Acute Lymphoblastic Leukemia (ALL); Results from the Children's Oncology Group (COG) Trial AALL15P1
Kairalla, John A. , Hibbitts, Emily , Carroll, Andrew J. , Heerema, Nyla A. , Kubaney, Holly R. , August, Amanda, Wechsler, Daniel S. , Miles, Rodney R., Kihei, Cynthia D., Gore, Lia , Raetz, Elizabeth A. , Brown, Patrick A. , Guest, Erin M. , Devidas, Meenakshi , Pauly, Melinda , Reid, Joel M. , Hunger, Stephen P. , Loh, Mignon L.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3256-3257
Five-Year Results and Overall Survival Update from the Phase 3 Randomized Study Augment: Lenalidomide Plus Rituximab (R2) Vs Rituximab Plus Placebo in Patients with Relapsed/Refractory Indolent Non-Hodgkin Lymphoma
Leonard, John P. , Offner, Fritz , Mayer, Jiří , Zhang, Huilai , Nowakowski, Grzegorz S. , Gkasiamis, Argyrios, Mikita-Geoffroy, Joanna, Rowe, Everton, Trněný, Marek , Scheinberg, Phillip , Gkasiamis, Argyrios, Gribben, John G.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 561-563
Early and Sustained Undetectable Measurable Residual Disease (MRD) after Idecabtagene Vicleucel (ide-cel) Defines a Subset of Multiple Myeloma (MM) Patients in Karmma Achieving Prolonged Survival
Manrique, Irene , Campbell, Timothy , Kazanecki, Christian C. , Martin, Nathan , Kaiser, Shari M. , Anderson, Larry D. , Lin, Yi , Munshi, Nikhil C. , Anderson, Larry D , Paiva, Bruno , Rytlewski, Julie , Berdeja, Jesús G. , Lonial, Sagar , Raje, Noopur , Moreau, Philippe , Miguel, Jesús F. San
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 2104-2105
Synergistic Immunostimulatory Effects and Therapeutic Benefit of Combined T Cell Engager and Cytotoxic Therapy in a Multiple Myeloma Preclinical Model
Zhu, Yuan Xiao , Du, Megan T. , Welsh, Seth J. , Wheeler, Matthew L, Chesi, Marta, Meermeier, Erin W. , Stein, Caleb K. , Sharik, Meaghen E. , Shi, Chang-Xin , Wheeler, Matthew L, Bergsagel, P. Leif , Chesi, Marta
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 7056-7057
Impact of COVID-19 on Treatment Patterns and Management of Multiple Myeloma: Insights from the Connect® MM Registry
Terebelo, Howard R. , Abonour, Rafat , Durie, Brian G.M. , Omel, James L., Narang, Mohit , Toomey, Kathleen, Rifkin, Robert M. , Gasparetto, Cristina, Yu, Edward, Anand, Jasmeet, Liu, Liang , Jou, Ying‐Ming, Jagannath, Sundar, Richter, Joshua , Ailawadhi, Sikander , Lee, Hans C. , Hardin, James W. , Wagner, Lynne I. , Omel, James, Gasparetto, Cristina , Jagannath, Sundar
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 8089-8091
Iberdomide (CC-220) Monotherapy or in Combination with an Anti-CD20 Monoclonal Antibody As Effective Therapy in Patients with Relapsed/Refractory Lymphoma: Early Results from a Phase 1/2 Study
Thiéblemont, Catherine , Visco, Carlo , Gastinne, Thomas , Bouabdallah, Kamal , Nowakowski, Grzegorz S. , Roulin, Louise , Topp, Max S. , Jauhari, Shekeab , Vučinić, Vladan , Martin, Peter , Gkasiamis, Argyrios, Drew, James, Rao, Parth, Cheng, Yiming , Muñoz, Javier , Tucci, Alessandra , Cartron, Guillaume , Corradini, Paolo , Flinn, Ian W. , Arcaini, Luca , Kaplan, Mark H. , Li, Ju, Morschhauser, Franck
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 569-572
Biological Features of a High-Risk Transcriptional Molecular Subtype in Diffuse Large B-Cell Lymphoma
Stokes, Matthew E. , Wenzl, Kerstin , Huang, C. Chris , Estévez, María Ortiz, Hagner, Patrick R. , Hsu, Chih-Chao , Danziger, Samuel A. , King, Rebecca L. , Sarangi, Vivekananda , Asmann, Yan W. , Sudhindra, Akshay, Ansell, Stephen M. , Nowakowski, Grzegorz S. , Novak, Anne J. , Gandhi, Anita K. , Maurer, Matthew J. , Stong, Nicholas , Nakayama, Yumi , Hsu, Chih-Chao , Towfic, Fadi , Parker, Joel S. , Link, Brian K. , Slager, Susan L. , Novak, Joseph P. , Habermann, Thomas M. , Cerhan, James R.
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 3548-3550
Lisocabtagene Maraleucel (liso-cel) Versus Standard of Care (SOC) with Salvage Chemotherapy Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients with Relapsed or Refractory Large B-Cell Lymphoma (LBCL): Primary
Solomon, Scott R. , Arnason, Jon , Johnston, Patrick B., Glaß, Bertram , Mielke, Stephan , Mutsaers, Pim , Hernandez‐Ilizaliturri, Francisco J. , Lunning, Matthew A. , Crotta, Alessandro, Montheard, Sandrine, Previtali, Alessandro , Mielke, Stephan , Abramson, Jeremy S. , Johnston, Patrick B. , Bachanová, Veronika , Ibrahimi, Sami , Izutsu, Koji , Morschhauser, Franck , Kamdar, Manali
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 1581-1583
Outcomes of Second-Line (2L) Triplet+ Regimens in Patients with Relapsed/Refractory Multiple Myeloma (MM) Following Progression after First-Line (1L) Lenalidomide in the Connect® MM Disease Registry
Abonour, Rafat , Durie, Brian G.M. , Gasparetto, Cristina, Narang, Mohit , Omel, James, Rifkin, Robert M. , Terebelo, Howard R. , Toomey, Kathleen, Slaff, Samantha, Danforth, Dailan, Chung, Weiyuan, Anand, Jasmeet, Yu, Edward, Tang, Derek, Jagannath, Sundar, Lee, Hans C. , Ailawadhi, Sikander , Gasparetto, Cristina , Hardin, James W. , Wagner, Lynne I. , Jagannath, Sundar
Blood | November 28, 2022 | Volume: 140 | Issue: Supplement 1 | Pages: 13256-13258